HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Feng-yuan Li Selected Research

Feng-yuan Li Research Topics

Disease

1Type 2 Diabetes Mellitus (MODY)
02/2013
1Chronic Periodontitis
02/2013
1Ductal Carcinoma
01/2009
1Neoplasms (Cancer)
01/2006
1Necrosis
01/2006
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
12/2005
1Latent Infection
09/2005
1Celiac Disease (Celiac Sprue)
09/2005
1T-Cell Lymphoma (Lymphoma, T Cell)
09/2005
1Lymphoma (Lymphomas)
06/2005
1Psoriasis (Pustulosis Palmaris et Plantaris)
09/2004
1Ulcerative Colitis
09/2004
1Inflammation (Inflammations)
09/2004
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
07/2004

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
12/2005 - 07/2004
1Blood Glucose (Blood Sugar)IBA
02/2013
1Biomarkers (Surrogate Marker)IBA
02/2013
1ParaffinIBA
01/2009
1Immunoglobulin G (IgG)IBA
01/2006
1Amyloid (Amyloid Fibrils)IBA
01/2006
1Immunoglobulin A (IgA)IBA
01/2006
1Immunoglobulin M (IgM)IBA
01/2006
1B-Cell CLL-Lymphoma 10 ProteinIBA
12/2005
15- (benzoylamino)- N- (4- chlorophenyl)- 3- methyl- 4- isothiazolecarboxamide (ITCL)IBA
09/2005
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
09/2005
1PAX5 Transcription FactorIBA
06/2005
1GlucocorticoidsIBA
09/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2004
1Cell Adhesion MoleculesIBA
09/2004
1glucocorticoid receptor betaIBA
09/2004
1glucocorticoid receptor alphaIBA
09/2004
1HLA Antigens (Human Leukocyte Antigens)IBA
09/2004
1HLA-DR Antigens (HLA-DR)IBA
09/2004

Therapy/Procedure

2Therapeutics
02/2013 - 09/2004
1Aftercare (After-Treatment)
09/2004